Precision Oncology: 2022 in Review.

Rosen, Ezra; Drilon, Alexander; Chakravarty, Debyani

Rosen, Ezra; Drilon, Alexander; Chakravarty, Debyani.

Afiliación

Rosen E; Memorial Sloan Kettering Cancer Center, New York, New York.
Drilon A; Memorial Sloan Kettering Cancer Center, New York, New York.
Chakravarty D; Memorial Sloan Kettering Cancer Center, New York, New York.

Cancer Discov ; 12(12): 2747-2753, 2022 12 02.

Article en En | MEDLINE | ID: mdl-36458431

ABSTRACT

ABSTRACT

This article presents a review of the major advances and future implications in precision oncology accomplished in 2022 and centers on three primary pillars advances in (i) rational drug design, (ii) study design, and (iii) novel biomarkers.

Asunto(s)

Neoplasias; Humanos; Neoplasias/tratamiento farmacológico; Neoplasias/genética; Medicina de Precisión; Oncología Médica; Proyectos de Investigación; Diseño de Fármacos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Discov Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google